Medical Policy Updates

Notification of Policy Revisions Effective October 1, 2021 (Posted July 1, 2021)

Policy Name Revision
Intravenous Iron Replacement Therapy “Notification” Original medical policy criteria issued. Policy notification given 7/1/2021 for effective date 10/1/2021.
Ocular Angiogenesis Inhibitor Agents “Notification” Original medical policy criteria issued. Policy notification given 7/1/2021 for effective date 10/1/2021.